Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

News

 

Virtus grows in Denmark, targets international patients

Australia-based fertility specialist Virtus Health has a new showpiece clinic in Copenhagen. HBI hears it is targeting both locals and medical tourists, and speaks to a source to find out more about the appeal of the Danish market.

Cinven looking to take Synlab private

London headquartered global PE firm Cinven has submitted a non-binding offer to fully take over Europe's largest lab group Synlab, the company confirmed today, following speculation it was looking to take the group private.

FutureLife acquires again in Spain

Czechia-based fertility group FutureLife continues to expand in Spain with its latest acquisition. HBI chats with a European fertility operator to find out what is making the Spanish market appealing to investors.

Merger strengthens Medigold’s occupational health offering

Medigold, one of the UK’s largest occupational health care providers, is acquiring Health Management, a major competitor, in a deal that will make it the UK's largest provider of occupational health in terms of number of employees covered.

Reconciling payor-provider tensions

Relationships between payors and providers can be notoriously tricky. As attendees at the recent IFC conference in Cape Town, South Africa heard, the difference is often over how value is defined - and as providers grow, the balance of power is shifting.

KPJ Healthcare exiting Indonesia citing rules imposed on foreign operators

KPJ Healthcare Bhd, Malaysia’s second largest for-profit hospital group by revenue, is to sell its Indonesian hospital operations to rival Columbia Asia Healthcare. This will mark its exit from the country. Luxembourg-based PE firm CVC Capital Partners is reportedly considering buying a minority stake in the group.

Spire returns to profit, but shares still fall

Shareholders did not give UK hospital group Spire’s full year results a warm reception, despite a return to profit, generally strong financials, and the continued viability of the UK market. HBI talks to market experts to find out why.

Find Us